Literature DB >> 24881119

Chemical and physical compatibility of an intravenous solution of epinephrine with calcium chloride.

Phillip A Weeks, Yang Teng, Lei Wu, Mary Sun, Zhen Yang, Diana S-L Chow.   

Abstract

An infusion of epinephrine combined with calcium chloride has been used historically as an intravenous inotropic solution to support critically ill heart failure patients with severe cardiogenic shock. There is no reliable data on the stability of this solution beyond three hours. This study was conducted to evaluate the chemical and physical compatibility of epinephrine (0.032 mg/mL) combined with calcium chloride (4 mg/mL) in a solution for intravenous administration up to 26 hours at room temperature. The chemical stability of epinephrine was monitored by measuring epinephrine concentrations using high-performance liquid chromatography. The physical compatibility of the mixture was determined by measuring spectrophotometric absorbance between 400 to 700 nm. Absorbance greater than 0.010 AU was considered an indicator of the presence of precipitation. The results showed epinephrine with calcium chloride was stable together in normal saline up to 26 hours at room temperature, irrespective of exposure to light. The absorbance of epinephrine throughout the study was less than 0.010 AU, indicating no significant precipitation. Conclusions indicate that epinephrine (0.032 mg/mL) combined with calcium chloride (4 mg/mL) in normal saline at room temperature is acceptably stable up to 26 hours for intravenous administration.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24881119

Source DB:  PubMed          Journal:  Int J Pharm Compd        ISSN: 1092-4221


  1 in total

1.  Calcium Chloride Infusions are Not Associated with Improved Outcomes in Neonates Undergoing Cardiac Operations.

Authors:  Laura E Murray; Holly Burchett; Shahryar M Chowdhury; A Lauren Haney; Marc Hassid; Jacob R Strelow; Eric M Graham; Minoo N Kavarana; Jason R Buckley
Journal:  Pediatr Cardiol       Date:  2021-09-14       Impact factor: 1.838

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.